Page 1 of 1
1. A patient with pneumocystis jiroveci is receiving intravenous Sulfamethoxazole/Trimethoprim (Bactrim). The medication
Posted: Tue Mar 15, 2022 3:00 pm
by answerhappygod
- 1 A Patient With Pneumocystis Jiroveci Is Receiving Intravenous Sulfamethoxazole Trimethoprim Bactrim The Medication 1 (44.08 KiB) Viewed 33 times
1. A patient with pneumocystis jiroveci is receiving intravenous Sulfamethoxazole/Trimethoprim (Bactrim). The medications are mixed in 500ml of 5% Dextrose in Water to infuse over 90 minutes. What is the rationale for using this amount of IV fluid? A. To prevent hypotension. B. To maintain hydration. C. To maintain fluid and electrolyte balance. D. To prevent crystalluria.